CORRECTION – Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
August 15, 2024 12:17 ET
|
Tevogen Bio Inc
Tevogen Bio Reports Second Quarter 2024 Financial Results
Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
August 15, 2024 09:00 ET
|
Tevogen Bio Inc
Tevogen Bio Reports Second Quarter 2024 Financial Results
Nano Dimension Announces Conference Call to Discuss Q2/2024 Quarterly Results
August 13, 2024 08:00 ET
|
Nano Dimension Ltd.
Waltham, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and...
Berry Corporation to Report Second Quarter 2024 Results and Hold Conference Call August 9
July 30, 2024 07:00 ET
|
Berry Corporation (Bry)
DALLAS, July 30, 2024 (GLOBE NEWSWIRE) -- Berry Corporation (NASDAQ: BRY) (“Berry” or the “Company”) today announced it will report second quarter 2024 results on Friday, August 9, 2024, before the...
First Financial Northwest, Inc. Reports Net Income of $1.6 Million or $0.17 Per Diluted Share for the Second Quarter Ended June 30, 2024
July 25, 2024 09:10 ET
|
First Financial Northwest, Inc.
RENTON, Wash., July 25, 2024 (GLOBE NEWSWIRE) -- First Financial Northwest, Inc. (the “Company”) (NASDAQ GS: FFNW), the holding company for First Financial Northwest Bank (the “Bank”), today...
Goodfellow annonce ses résultats pour son deuxième trimestre terminé le 31 mai 2024
July 10, 2024 19:41 ET
|
Goodfellow inc.
DELSON, Québec, 10 juill. 2024 (GLOBE NEWSWIRE) -- Goodfellow inc. (TSX : GDL) (la « Société » ou « Goodfellow ») annonce aujourd’hui ses résultats financiers pour le deuxième trimestre terminé...
Goodfellow Reports Its Results for the Second Quarter Ended May 31, 2024
July 10, 2024 19:41 ET
|
Goodfellow Inc.
Q2 financial results / Résultats financiers T2
Tevogen Bio Reports First Quarter 2024 Financial Results
May 29, 2024 08:00 ET
|
Tevogen Bio Inc
Tevogen Bio first quarter '24 financial results: Liability elimination of $94.9M. $11.3M of net income. Net cash operations $2.1M. $36M LOC.
Aedifica NV/SA: Interim financial report – Q1 2024
May 02, 2024 01:30 ET
|
Aedifica
Please find below Aedifica’s interim financial report for the 1st quarter of the 2024 financial year. Robust operational performance driving strong results ahead of budget EPRA Earnings* amounted to...
Goodfellow annonce ses résultats pour son premier trimestre terminé le 29 février 2024
April 11, 2024 17:00 ET
|
Goodfellow inc.
DELSON, Québec, 11 avr. 2024 (GLOBE NEWSWIRE) -- Goodfellow inc. (TSX : GDL) (la « Société » ou « Goodfellow ») annonce aujourd’hui ses résultats financiers pour le premier trimestre terminé le...